Congenital abnormalities and hormones during pregnancy: a clinical review

Teratology
J L Schardein

Abstract

A review of the extensive literature on the subject indicates that sex hormones have been associated with a wide variety of adverse clinical conditions following usage during pregnancy. About 230 cases of female pseudohermaphroditism have been reported following use of hormones with androgenic potency, but masculinization observed with estrogens in a few females may represent only adrenal-stimulated pseudohermaphroditism. Feminization of males, mostly by progestogens in some 45 cases, is unproven at present. Realizing the limitations of the published studies when all present data are considered, there seems no justification for undue concern over the induction of nongenital congenital malformations through hormone use in pregnancy. The available data on the association to cardiac, limb, and CNS defects, and to several malformative syndromes, are not convincing: the effects appear to be remarkably nonspecific, the studies are contradicted by a large number of negative reports, and an increased incidence of defects with increased usage has not materialized. A possible exception are the CNS malformations associated with the use of the antifertility agent clomiphene, and careful surveillance is warranted at present. While a reasona...Continue Reading

Associated Clinical Trials

References

Mar 22, 1975·Lancet·D T Janerich
Mar 12, 1977·Lancet·W H James
Nov 5, 1977·Lancet·I F Roberts, R J West
Aug 1, 1976·British Journal of Obstetrics and Gynaecology·D T JanerichM D Keogh
Jun 1, 1975·American Journal of Diseases of Children·C K HoW H McAlister
Jan 1, 1979·Journal of Chronic Diseases·D T JanerichM B Hoff
Jan 1, 1977·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·L Keith, G S Berger
Jan 11, 1979·The New England Journal of Medicine·D Aarskog
Jan 1, 1979·Fertility and Sterility·C A LorberE Engel
Jul 1, 1978·The Journal of Pediatrics·M Singh, S Singhi
Sep 1, 1978·JAMA : the Journal of the American Medical Association·J J NoraW J Kimberling
Sep 7, 1978·The New England Journal of Medicine·K J Rothman, C Louik
Jan 1, 1978·Acta Obstetricia Et Gynecologica Scandinavica·Y BialeN Ben-Aderet
Dec 1, 1978·International Journal of Epidemiology·M B BrackenJ L Kelsey
Jan 13, 1977·The New England Journal of Medicine·O P HeinonenS Shapiro
Mar 1, 1977·British Journal of Obstetrics and Gynaecology·D D Mathews
Apr 23, 1977·British Medical Journal·D T JanerichL Strite
Aug 1, 1977·Fertility and Sterility·L M AmbaniP K Devi
Oct 1, 1977·British Medical Journal·G GreenbergJ C Haskey
Jan 1, 1976·Acta Obstetricia Et Gynecologica Scandinavica·S Kullander, B Källén
Jan 1, 1976·Acta Obstetricia Et Gynecologica Scandinavica·M AhlgrenG Rannevik
Dec 1, 1976·British Journal of Obstetrics and Gynaecology·E CaspiM D Goldberg
Jan 1, 1975·Archives of Environmental Health·A H Nora, J J Nora
Apr 26, 1975·British Medical Journal·G GreenbergA M Adelstein
Mar 1, 1976·The Journal of Pediatrics·A PappG Y Ruzicska
Mar 1, 1976·Acta paediatrica Scandinavica·J ApoldD Aarskog
Oct 15, 1970·American Journal of Obstetrics and Gynecology·H G McQuarrieR A Stone
Jul 10, 1971·Lancet·L I GardnerR L Neu
Jun 2, 1973·Lancet·J L Dyson, H G Kohler
Jun 16, 1973·Lancet·R L Kaufman
Jul 14, 1973·Lancet·D T JanerichD M Glebatis
Apr 28, 1973·Lancet·J J Nora, A H Nora
Aug 4, 1973·Lancet·G P OakleyA Falek
Aug 18, 1973·Lancet·B Sandler
Nov 10, 1973·Lancet·S BalciA Hicsönmez
Jun 15, 1974·Lancet·T J David, S E O'Callaghan

❮ Previous
Next ❯

Citations

Mar 28, 1998·Teratology·M L Martínez-FríasL Prieto
Jan 1, 1983·American Journal of Industrial Medicine·A P Polednak, D T Janerich
Nov 1, 1992·European Journal of Epidemiology·P Pradat
Jan 1, 1995·Obstetrics and Gynecology·L Raman-WilmsG Koren
Apr 1, 1983·Prostaglandins·R G RahwanD T Witiak
Mar 3, 1983·The New England Journal of Medicine·H Kalter, J Warkany
Apr 17, 1998·The New England Journal of Medicine·G KorenS Ito
Sep 12, 2003·The New England Journal of Medicine·Leo R BrancazioR Phillps Heine
Jun 13, 2003·The New England Journal of Medicine·Paul J MeisUNKNOWN National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network
Jan 1, 1991·Drug and Alcohol Review·J Price
Dec 6, 1986·British Medical Journal·M J Whittle, K P Hanretty
Dec 1, 1986·Environmental Health Perspectives·D NeubertC Lewandowski
Dec 17, 2011·Women's Health·Simi Gupta, Ashley S Roman
May 3, 2005·Obstetrics and Gynecology·Paul J Meis, UNKNOWN Society for Maternal-Fetal Medicine
Oct 2, 2007·Obstetrics and Gynecology·Allison T NorthenUNKNOWN National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network
Aug 2, 2007·Obstetrics and Gynecology·Catherine Y Spong
Apr 18, 2007·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·M S ChristianP Calda
Sep 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A AddisM Bonati
Nov 29, 2011·Reproductive Toxicology·Paul MerlobGil Klinger
May 18, 2011·Obstetrics and Gynecology Clinics of North America·Nicole Ruddock Hall
Jan 1, 1988·Reproductive Toxicology·A R Scialli
Jun 5, 2007·Regulatory Toxicology and Pharmacology : RTP·James J CollinsMichael P Holsapple
Oct 6, 2005·Birth Defects Research. Part A, Clinical and Molecular Teratology·Robert L Brent
Aug 3, 2011·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Kenneth Apen, Shveta Kapoor
Apr 25, 2012·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·James L SchardeinBjorn A Thorsrud
Jan 7, 2014·Pharmacotherapy·Leda L Ramoz, Nima M Patel-Shori
Oct 12, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Marco De SantisAlessandro Caruso
Jan 1, 1989·Annals of the New York Academy of Sciences·N K MelloS K Teoh
Oct 1, 1986·Teratology·E J LammerM J Khoury

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.